HighGravityDataModerna — Aug 1, 2025 release
Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001682852-25-000041
Showing in the filing
Total headcount
“under 5,000”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 15
Projected revenue range for FY2025
“$1.5 to $2.2 billion”
Revenue for FY2025
“$1.5 to $2.2 billion”
Expected GAAP operating expenses for FY2025
“$5.9 to $6.1 billion”
Expected year-end cash balance for FY2025
“approximately $6 billion”
Year-end cash and investments for FY2025
“approximately $6 billion”
Revenue split for H2 FY2025
“40-50% in the third quarter with the balance in the fourth quarter of 2025”
Revenue split for Q3 FY2025
“40-50%”
Second half 2025 revenue split for Q3 FY2025
“40-50% in the third quarter with the balance in the fourth quarter”
Cost of sales for FY2025
“approximately $1.2 billion”
Research and development expenses for FY2025
“$3.6 to $3.8 billion”
Selling, general and administrative expenses for FY2025
“approximately $1.1 billion”
Income Taxes for FY2025
“negligible”
Tax expense for FY2025
“negligible”
Capital expenditures for FY2025
“approximately $0.3 billion”
Total headcount for FY2025
“under 5,000”
Exhibit 99.1 · the passage around this item
… earlier in the release
The FDA and Moderna have agreed on the pivotal study design. The Company expects to start a registrational study in 2025. Moderna Corporate Updates • Moderna announced an organizational restructuring that will reduce its global workforce by approximately 10%. The Company anticipates a total headcount of under 5,000 by year-end. Company Accolades • Moderna was named to the Boston Business Journal 's annual list of the Most Charitable Companies in Massachusetts (third consecutive year) • Moderna was recognized as a top-scoring company on Disability:IN's Disability Equality Index and a Best Place to Work for Disability Inclusion (fourth consecutive year) Key 2025 Investor and Analyst Event Dates • Analyst Day: November 20 4 Investor Call and Webcast Information Moderna will host a live conference call and webcast at 8:00 a.m. ET on August 1, 2025. To access the live conference call via telephone, please register at the link below. Once registered, dial-in numbers and a unique pin number will be provided. A live webcast of the call will also be available under "Events and Presentations" in the Investors section of the Moderna website. • Telephone: https://register-conf.media-server.com/register/BI6a2a760e286448f68f4b751fb8f31848 • Webcast: https://investors.modernatx.com The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call. About Moderna Moderna is a leader in the creation of the field
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.